Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Oosterlinck

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Urologia Internationalis|November 8, 2014
Transurethral resection of the prostate in recurrent acute bacterial prostatitisKarel Decaestecker, Willem Oosterlinck
European Urology|December 12, 2017
Re: Active Surveillance for Low-risk Nonmuscle Invasive Bladder Cancer (NMIBC): a Confirmatory and Resource Consumption Study from Bladder Cancer Italian Active Surveillance (BIAS) ProjectWillem Oosterlinck, Karel Decaestecker
Expert Review of Anticancer Therapy|October 4, 2012
Current strategies in the treatment of non-muscle-invasive bladder cancerWillem Oosterlinck, Karel Decaestecker
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 2, 2009
Challenging non-traumatic posterior urethral strictures treated with urethroplasty: a preliminary reportNicolaas Lumen, Willem Oosterlinck
European Urology|July 9, 2008
Re: Guido Barbagli, Giorgio Guazzoni, Massimo Lazzeri. One-stage bulbar urethroplasty: retrospective analysis of the results in 375 patients. Eur Urol 2008;53:828-33Willem Oosterlinck, Nicolaas Lumen
Translational Andrology and Urology|January 29, 2019
An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancersWillem Oosterlinck, Karel Decaestecker
Research and Reports in Urology|November 26, 2015
Managing the adverse events of intravesical bacillus Calmette-Guérin therapyKarel Decaestecker, Willem Oosterlinck
The Journal of Urology|September 23, 2008
Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106Willem Oosterlinck, Richard Sylvester
European Urology|December 4, 2014
The correct sequence of intravesical chemotherapy and bacillus Calmette-Guérin for non-muscle-invasive bladder cancerWillem Oosterlinck, Karel Decaestecker
European Urology|April 21, 2009
An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?Richard J Sylvester, Willem Oosterlinck
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Urologia Internationalis|November 8, 2014
Transurethral resection of the prostate in recurrent acute bacterial prostatitisKarel Decaestecker, Willem Oosterlinck
European Urology|December 12, 2017
Re: Active Surveillance for Low-risk Nonmuscle Invasive Bladder Cancer (NMIBC): a Confirmatory and Resource Consumption Study from Bladder Cancer Italian Active Surveillance (BIAS) ProjectWillem Oosterlinck, Karel Decaestecker
Expert Review of Anticancer Therapy|October 4, 2012
Current strategies in the treatment of non-muscle-invasive bladder cancerWillem Oosterlinck, Karel Decaestecker
International Braz J Urol : Official Journal of the Brazilian Society of Urology|September 2, 2009
Challenging non-traumatic posterior urethral strictures treated with urethroplasty: a preliminary reportNicolaas Lumen, Willem Oosterlinck
European Urology|July 9, 2008
Re: Guido Barbagli, Giorgio Guazzoni, Massimo Lazzeri. One-stage bulbar urethroplasty: retrospective analysis of the results in 375 patients. Eur Urol 2008;53:828-33Willem Oosterlinck, Nicolaas Lumen
Translational Andrology and Urology|January 29, 2019
An immediate intravesical instillation of mitomycin C is of benefit in all prognostic risk groups with non-muscle-invasive bladder cancersWillem Oosterlinck, Karel Decaestecker
Research and Reports in Urology|November 26, 2015
Managing the adverse events of intravesical bacillus Calmette-Guérin therapyKarel Decaestecker, Willem Oosterlinck
The Journal of Urology|September 23, 2008
Re: A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences: I. Berrum-svennung, T. Granfors, S. Jahnson, H. Boman and S. Holmang. J Urol 2008; 179: 101-106Willem Oosterlinck, Richard Sylvester
European Urology|December 4, 2014
The correct sequence of intravesical chemotherapy and bacillus Calmette-Guérin for non-muscle-invasive bladder cancerWillem Oosterlinck, Karel Decaestecker
European Urology|April 21, 2009
An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed?Richard J Sylvester, Willem Oosterlinck
Pageof 8